source
- Australian regulator seeks feedback on adding unique device IDs to medical device free‑sale certificatesAustralia’s Therapeutic Goods Administration (TGA) announced it is reviewing whether to include unique device identification (UDI) details on certificates of free sale that accompany medical device…
- FDA denies Summit Therapeutics' ivonescimab for EGFR-mutated lung cancer, halting US entryThe U.S. Food and Drug Administration issued a complete response letter rejecting Summit Therapeutics' biologics license application for ivonescimab, a PD-1xVEGF bispecific antibody intended for EG…